MECOM and acute myeloid leukemia: Our microarray data using primary bone marrow (BM) progenitors with forced expression of Evi1 and some sets of published gene expression data from AML samples [4,34] were combined and bioinformatically analyzed, leading to the identification of the tumor suppressor PTEN as a novel repressive target of Evi1.